https://www.selleckchem.com/products/FTY720.html
N12616000206426; URL www.anzctr.org.au. Pulmonary arterial hypertension (PAH) is a progressive disease associated with significant morbidity and mortality. Despite the negative impact of PAH on quality of life and survival, data on use of specialty palliative care services (PCS) is scarce. We sought to evaluate the inpatient use of PCS in patients with PAH. Using the National (Nationwide) Inpatient Sample, 30,495 admissions with a primary diagnosis of PAH were identified from 2001 through 2017. The primary outcome of interest was tempora
Like
Comment
Share
